Humacyte, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Humacyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $30.00K.
- Humacyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $56.00K, a 2700.00% increase year-over-year.
- Humacyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $495.00K, a 400.00% increase year-over-year.
- Humacyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $787.00K, a 728.42% increase year-over-year.
- Humacyte, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $61.00K, a 95.96% decline from fiscal 2024.
- Humacyte, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.51M, a 166.96% increase from fiscal 2023.
- Humacyte, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $566.00K, a 5.79% increase from fiscal 2022.
- Humacyte, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $535.00K, a 10.54% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $61.00K 10-K · filed 2026-03-27 | |
| 2025-03-31 | $56.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $1.51M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $495.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $787.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $2.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $566.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $99.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $95.00K 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $119.00K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $535.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $217.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $11.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $598.00K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $360.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $30.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $206.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $301.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $48.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $175.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |